Cairo – Mubasher: Egyptian International Pharmaceutical Industries (EIPICO) said its consolidated profit grew 14.9% for the fiscal year of 2015.
The company’s FY15 consolidated profit reached EGP 393.7 million, compared with EGP 342.7 million for 2014.
The board of director proposed to pay out cash dividends for 2015 at EGP 3.5 a share, compared to EGP 3.3 a share last year.
The pharmaceutical company invited its shareholders to attend the ordinary general meeting on 30 March for considering the board’s report, auditors’ report, as well as 2015 cash dividends.
On 14 March, the stock’s close quote rise by 2.3% to EGP 60.9.
